198 related articles for article (PubMed ID: 31129513)
21. [Effect of acetyl-11-keto-β-boswellic acid on proliferation, apoptosis and cell cycle of human acute myeloid leukemia cell line HL-60].
Yuan XY; Li YH; Qi ZH; Peng MY; Wan Z; Wang GP; Chen FP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec; 18(6):1440-4. PubMed ID: 21176347
[TBL] [Abstract][Full Text] [Related]
22. Acetyl-11-keto-beta-boswellic acid potentiates apoptosis, inhibits invasion, and abolishes osteoclastogenesis by suppressing NF-kappa B and NF-kappa B-regulated gene expression.
Takada Y; Ichikawa H; Badmaev V; Aggarwal BB
J Immunol; 2006 Mar; 176(5):3127-40. PubMed ID: 16493072
[TBL] [Abstract][Full Text] [Related]
23. Acetyl-11-keto-beta-boswellic acid (AKBA) prevents human colonic adenocarcinoma growth through modulation of multiple signaling pathways.
Yuan Y; Cui SX; Wang Y; Ke HN; Wang RQ; Lou HX; Gao ZH; Qu XJ
Biochim Biophys Acta; 2013 Oct; 1830(10):4907-16. PubMed ID: 23850473
[TBL] [Abstract][Full Text] [Related]
24. Reversal of Chemoresistance in Ovarian Cancer by Co-Delivery of a P-Glycoprotein Inhibitor and Paclitaxel in a Liposomal Platform.
Zhang Y; Sriraman SK; Kenny HA; Luther E; Torchilin V; Lengyel E
Mol Cancer Ther; 2016 Oct; 15(10):2282-2293. PubMed ID: 27466355
[TBL] [Abstract][Full Text] [Related]
25. Acetyl-11-keto-beta-boswellic acid inhibits cell proliferation and growth of oral squamous cell carcinoma via RAB7B-mediated autophagy.
Pan D; Wang Q; Tang S; Wu X; Cai L; Wang Z; Li Y; Huang M; Zhou Y; Shen YQ
Toxicol Appl Pharmacol; 2024 Apr; 485():116906. PubMed ID: 38513840
[TBL] [Abstract][Full Text] [Related]
26. Octreotide reverses the resistance of A2780/Pacliaxel ovarian cancer cell line to paclitaxel chemotherapy in vitro.
Shen Y; Zhang XY; Chen X; Ren ML; Cai YL
J Cancer Res Ther; 2016; 12(2):657-62. PubMed ID: 27461627
[TBL] [Abstract][Full Text] [Related]
27. MiR-27a modulates MDR1/P-glycoprotein expression by targeting HIPK2 in human ovarian cancer cells.
Li Z; Hu S; Wang J; Cai J; Xiao L; Yu L; Wang Z
Gynecol Oncol; 2010 Oct; 119(1):125-30. PubMed ID: 20624637
[TBL] [Abstract][Full Text] [Related]
28. Afatinib reverses multidrug resistance in ovarian cancer via dually inhibiting ATP binding cassette subfamily B member 1.
Wang SQ; Liu ST; Zhao BX; Yang FH; Wang YT; Liang QY; Sun YB; Liu Y; Song ZH; Cai Y; Li GF
Oncotarget; 2015 Sep; 6(28):26142-60. PubMed ID: 26317651
[TBL] [Abstract][Full Text] [Related]
29. Synthetic paclitaxel-octreotide conjugate reversing the resistance of A2780/Taxol to paclitaxel in xenografted tumor in nude mice.
Chen X; Zhang XY; Shen Y; Fan LL; Ren ML; Wu YP
Oncotarget; 2016 Dec; 7(50):83451-83461. PubMed ID: 27825139
[TBL] [Abstract][Full Text] [Related]
30. Trametenolic acid B reverses multidrug resistance in breast cancer cells through regulating the expression level of P-glycoprotein.
Zhang Q; Wang J; He H; Liu H; Yan X; Zou K
Phytother Res; 2014 Jul; 28(7):1037-44. PubMed ID: 25289403
[TBL] [Abstract][Full Text] [Related]
31. Cross-reacting material 197 reverses the resistance to paclitaxel in paclitaxel-resistant human ovarian cancer.
Tang XH; Deng S; Li M; Lu MS
Tumour Biol; 2016 Apr; 37(4):5521-8. PubMed ID: 26572150
[TBL] [Abstract][Full Text] [Related]
32. [Reversal effect of MDR1 and MDR3 gene silencing on resistance of A2780/taxol cells to paclitaxel].
Xiao L; Gao R; Lu S; Lu MS; Liang ML; Ren LR; Wang ZH
Zhonghua Fu Chan Ke Za Zhi; 2007 Jun; 42(6):412-6. PubMed ID: 17697605
[TBL] [Abstract][Full Text] [Related]
33. RNAi targeting STMN alleviates the resistance to taxol and collectively contributes to down regulate the malignancy of NSCLC cells in vitro and in vivo.
Long D; Yu T; Chen X; Liao Y; Lin X
Cell Biol Toxicol; 2018 Feb; 34(1):7-21. PubMed ID: 28589243
[TBL] [Abstract][Full Text] [Related]
34. Multidrug resistant lncRNA profile in chemotherapeutic sensitive and resistant ovarian cancer cells.
Xu J; Wu J; Fu C; Teng F; Liu S; Dai C; Shen R; Jia X
J Cell Physiol; 2018 Jun; 233(6):5034-5043. PubMed ID: 29219179
[TBL] [Abstract][Full Text] [Related]
35. Acetyl-keto-beta-boswellic acid inhibits cellular proliferation through a p21-dependent pathway in colon cancer cells.
Liu JJ; Huang B; Hooi SC
Br J Pharmacol; 2006 Aug; 148(8):1099-107. PubMed ID: 16783403
[TBL] [Abstract][Full Text] [Related]
36. Establishment and characterization of adriamycin-resistant human colorectal adenocarcinoma HCT-15 cell lines with multidrug resistance.
Uchiyama-Kokubu N; Watanabe T
Anticancer Drugs; 2001 Oct; 12(9):769-79. PubMed ID: 11593059
[TBL] [Abstract][Full Text] [Related]
37. The relationship between p38MAPK and apoptosis during paclitaxel resistance of ovarian cancer cells.
Lu M; Xiao L; Li Z
J Huazhong Univ Sci Technolog Med Sci; 2007 Dec; 27(6):725-8. PubMed ID: 18231754
[TBL] [Abstract][Full Text] [Related]
38. The role of topotecan for extending the platinum-free interval in recurrent ovarian cancer: an in vitro model.
Horowitz NS; Hua J; Gibb RK; Mutch DG; Herzog TJ
Gynecol Oncol; 2004 Jul; 94(1):67-73. PubMed ID: 15262121
[TBL] [Abstract][Full Text] [Related]
39. Boswellic acid suppresses growth and metastasis of human pancreatic tumors in an orthotopic nude mouse model through modulation of multiple targets.
Park B; Prasad S; Yadav V; Sung B; Aggarwal BB
PLoS One; 2011; 6(10):e26943. PubMed ID: 22066019
[TBL] [Abstract][Full Text] [Related]
40. Reversal of Ovarian Cancer Multidrug Resistance by a Combination of LAH4-L1-siMDR1 Nanocomplexes with Chemotherapeutics.
Guo N; Gao C; Liu J; Li J; Liu N; Hao Y; Chen L; Zhang X
Mol Pharm; 2018 May; 15(5):1853-1861. PubMed ID: 29621396
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]